betway必威登陆网址 (betway.com )学报››2023,Vol. 44››Issue (10): 779-784.DOI:10.3969/j.issn.2097-0005.2023.10.013

• 综述 •上一篇

微小RNA在病毒性心肌炎中的研究进展

张新悦1(), 韩波1,2()

  1. 1.山东大学齐鲁医学院,山东 济南 250012
    2.betway必威登陆网址 附属省立医院小儿心脏科,山东 济南 250021
  • 收稿日期:2023-05-09出版日期:2023-10-25发布日期:2023-12-12
  • 通讯作者:韩波
  • 作者简介:张新悦,硕士研究生,研究方向:小儿心脏科,E-mail:zxy1349322924@163.com
  • 基金资助:
    国家自然科学基金(81873498)

Advances in the study of miRNAs in viral myocarditis

Xinyue ZHANG1(), Bo HAN1,2()

  1. 1.Cheeloo College of Medicine,Shandong University,Jinan 250012,China
    2.Department of Pediatrics,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China
  • Received:2023-05-09Online:2023-10-25Published:2023-12-12
  • Contact:Bo HAN

摘要:

微小RNA(microRNA, miRNA)是一类进化上保守、单链的内源性非编码RNA,可参与多种疾病的发生发展,并参与心脏发育,在心脏重塑、心力衰竭、冠心病、高血压病等方面的研究不断取得新进展。病毒性心肌炎是一种常见的心血管疾病,多由柯萨奇病毒B3(Coxsackie virus B3, CVB3)感染引起,其发病机制目前仍未明确。多项研究表明,miRNAs与CVB3的感染、心脏的免疫应答以及心肌细胞凋亡等均相关,在病毒性心肌炎的发病中起重要调控作用,并可作为新的诊断标志物与治疗靶点。本文就miRNAs在病毒性心肌炎中的研究进展进行综述。

关键词:病毒性心肌炎,微小RNA,柯萨奇病毒,生物标志物

Abstract:

MicroRNAs(miRNAs) are a class of single-stranded, small (19-25 nucleotides), and endogenous non-coding RNAs with evolutionarily conserved sequences, which can participate in the development of a variety of diseases. miRNAs contribute to the development of heart, and progress has been made in the researches of cardiac remodeling, heart failure, coronary heart disease, hypertension and other aspects. Viral myocarditis is a common cardiovascular disease, mostly caused by Coxsackie virus B3 (CVB3) infection, which can cause death in severe cases, and its pathogenesis remains to be elucidated. Several studies have shown that miRNAs are associated with CVB3 infection, the immune response of the heart and cardiomyocyte apoptosis, which plays an important regulatory role in the pathogenesis of viral myocarditis and can be used as a new diagnostic marker and therapeutic target. This review summarizes the progress of miRNAs in viral myocarditis.

Key words:viral myocarditis,microRNA,coxsackie virus B3,biomarkers